305 related articles for article (PubMed ID: 34309219)
1. Cost-effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.
Yong M; Wu YQ; Howlett J; Ballreich J; Walgama E; Thamboo A
Int Forum Allergy Rhinol; 2021 Dec; 11(12):1626-1636. PubMed ID: 34309219
[TBL] [Abstract][Full Text] [Related]
2. Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps.
Scangas GA; Wu AW; Ting JY; Metson R; Walgama E; Shrime MG; Higgins TS
Laryngoscope; 2021 Jan; 131(1):E26-E33. PubMed ID: 32243622
[TBL] [Abstract][Full Text] [Related]
3. Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps.
Parasher AK; Gliksman M; Segarra D; Lin T; Rudmik L; Quast T
Int Forum Allergy Rhinol; 2022 Jun; 12(6):813-820. PubMed ID: 34874120
[TBL] [Abstract][Full Text] [Related]
4. Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease.
Mustafa SS; Vadamalai K; Scott B; Ramsey A
Am J Rhinol Allergy; 2021 May; 35(3):399-407. PubMed ID: 32967430
[TBL] [Abstract][Full Text] [Related]
5. Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Buchheit KM; Hacker J; Maurer R; McGill A; Ryan T; Bensko JC; Laidlaw TM
Clin Exp Allergy; 2023 Sep; 53(9):974-977. PubMed ID: 37246613
[No Abstract] [Full Text] [Related]
6. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis.
Oykhman P; Paramo FA; Bousquet J; Kennedy DW; Brignardello-Petersen R; Chu DK
J Allergy Clin Immunol; 2022 Apr; 149(4):1286-1295. PubMed ID: 34543652
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of dupilumab compared with endoscopic sinus surgery in patients with chronic rhinosinusitis with nasal polyps. Evaluation in Colombia, a developing country.
Alvarez L; Querubin J; Bedoya J; Mejia A; Sánchez J
Expert Rev Pharmacoecon Outcomes Res; 2023 Jun; 23(5):571-578. PubMed ID: 36976904
[TBL] [Abstract][Full Text] [Related]
8. Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab.
Bertlich M; Ihler F; Bertlich I; Weiss BG; Gröger M; Haubner F
Medicine (Baltimore); 2021 Oct; 100(40):e27471. PubMed ID: 34622875
[TBL] [Abstract][Full Text] [Related]
9. [Biologic therapy in patients with severe NSAID-exacerbated respiratory disease and previous aspirin desensitization : Results of a multicentric study].
Staufenberg AR; Frankenberger HK; Förster-Ruhrmann U; Spahn FC; Klimek L; Fruth K; Stihl C; Matthias C; Gröger M; Hagemann J
HNO; 2024 Jul; 72(7):473-483. PubMed ID: 38466409
[TBL] [Abstract][Full Text] [Related]
10. Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease-How to Choose.
Laidlaw TM; Chu DK; Stevens WW; White AA
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1462-1467. PubMed ID: 34999274
[TBL] [Abstract][Full Text] [Related]
11. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
12. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
[TBL] [Abstract][Full Text] [Related]
13. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
Hardison SA; Senior BA
J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
[TBL] [Abstract][Full Text] [Related]
14. Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease.
Pacheco CS; Brooks RM; White KM
Mil Med; 2023 Jul; 188(7-8):e2826-e2828. PubMed ID: 36383070
[TBL] [Abstract][Full Text] [Related]
15. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis.
Williams AN; Woessner KM
Curr Allergy Asthma Rep; 2008 May; 8(3):245-52. PubMed ID: 18589844
[TBL] [Abstract][Full Text] [Related]
17. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
Simon RA; Dazy KM; Waldram JD
Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
[TBL] [Abstract][Full Text] [Related]
18. Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?
Laidlaw TM; White AA
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):79-84. PubMed ID: 37778627
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab in chronic rhinosinusitis with nasal polyps: Real life data in a multicentric Sicilian experience.
Galletti C; Ragusa M; Sireci F; Ciodaro F; Barbieri MA; Giunta G; Grigaliute E; Immordino A; Lorusso F; Dispenza F; Freni F; Galletti F; Gallina S; La Mantia I; Galletti B
Am J Otolaryngol; 2024; 45(1):104106. PubMed ID: 37948824
[TBL] [Abstract][Full Text] [Related]
20. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
